Rani Therapeutics Holdings, Inc. Class A Common Stock

$0.8937
USD
Last updated on --.
24h volume2.02M
24h highest0.96000 USD
24h lowest0.89100 USD
24h Price movement-6.01%

RANI recent prices

24 Hours
-6.01%-$0.0571
30 days
-4.13%-$0.0385
60 days
+13.34%+$0.112
90 days
-34.29%-$0.4663

Key data

Previous close0.95080 USD
Market cap106.86M USD
Volume2.02M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.26000 USD
Net income (FY)-36.23M USD
Revenue (FY)3.17M USD
Last report dateMay 15, 2026

About Rani Therapeutics Holdings, Inc. Class A Common Stock

PHARMACEUTICAL PREPARATIONS
HeadquartersSAN JOSE
Employees (FY)69.00
Revenue per employee (FY)45.93K USD
Net income per employee (FY)-525.03K USD
Listed onNasdaq
Official website

RANI conversion tables

RANIRANI
USDUSD
0.5 RANI0.44685 USD
1 RANI0.8937 USD
5 RANI4.468 USD
10 RANI8.937 USD
USDUSD
RANIRANI
0.5 USD0.55947 RANI
1 USD1.118 RANI
5 USD5.594 RANI
10 USD11.18 RANI

FAQ

RANI is trading at $0.8937, -6.01% over the last 24 hours. Track live moves on the price chart at the top of this page.
The RANI stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. RANI is currently trading at $0.8937, -6.01% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on RANI price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. RANI's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from RANI; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against RANI's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Rani Therapeutics Holdings, Inc. Class A Common Stock's market cap is currently 106.86M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.02M
24h highest0.96000 USD
24h lowest0.89100 USD
24h Price movement-6.01%
RANIRANI
USDUSD
Start trade with RANI Perpetual